Cholesterol lowering drugs may prevent degenerative eye disease (macular degeneration)August 14, 2003Statins, the drugs used to lower blood cholesterol, may help prevent the degenerative eye disease known as age related maculopathy or macular degeneration, finds research in the British Journal of Ophthalmology. Macular degeneration is a major cause of irreversible visual impairment among adults in the UK and USA. Sufferers do not go blind, but find it virtually impossible to read, drive, or do tasks requiring fine, sharp, central vision. It is caused by the progressive break down of light sensitive cells in the macula, located in the centre of the retina at the back of the eye. Risk increases with age, and as yet there is no effective curative or preventive treatment. Smokers are thought to be more susceptible.
US researchers assessed 550 people newly diagnosed with macular degeneration and 5500 randomly selected people at one veterans’ medical facility between 1997 and 2001. All those taking part in the study were aged 50 or older. All those with macular degeneration were significantly more likely to have diabetes, high blood pressure, or vascular disease, but there were no differences between them and the comparison group in terms of arterial disease or lipid metabolism disorders. An overview of the drugs they had been prescribed showed that those with macular degeneration were 50% less likely to have been prescribed statins than those without. This was irrespective of whether patients were taking statins at the time or had taken them in the past, or what other medical conditions they had. The association was not found for sole use of other types of cholesterol lowering drugs. The authors caution that these are preliminary findings, and that a further long term trial is needed to investigate the effectiveness of statins in the treatment and prevention of macular degeneration. British Medical Journal (BMJ) | |||||||||||||||||||||
|
Related Cholesterol Current Events and Cholesterol News Articles Apple or pear shape is not main culprit to heart woes — it's liver fat For years, pear-shaped people who carry weight in the thighs and backside have been told they are at lower risk for high blood pressure and heart disease than apple-shaped people who carry fat in the abdomen. But new findings from nutrition researchers at Washington University School of Medicine in St. Louis suggest body-shape comparisons don't completely explain risk. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease. Understanding how oxidative stress impairs endothelial progenitor cell function Although its been over a decade since endothelial progenitor cells or EPCs, cells that circulate in the blood repairing and replacing the cells that line blood vessels, were identified, the field is still evolving. Estrogen therapy could be dangerous for women with existing heart risk Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. Researchers identify how binge drinking may drive heart disease As the holidays arrive, a group of researchers has identified the precise mechanisms by which binge drinking contributes to clogs in arteries that lead to heart attack and stroke, according to a study published today in the journal Atherosclerosis. A scientific breakthrough on the control of the bad cholesterol A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor Heart patients are often not treated in accordance with guidelines Many patients with cardiovascular disease are not given adequate drug therapy. This is the result of an international study. In the current edition of Deutsches Ärzteblatt International, Uwe Zeimer et al. present the German results of this prospective, one-year survey. MU study reveals effective anti-tobacco ads should either scare or disgust viewers Now's the perfect time to increase anti-smoking campaigns - Nov. 20 is the American Cancer Society's Great American Smokeout. Red, red wine: How it fights Alzheimer's Scientists call it the "French paradox" - a society that, despite consuming food high in cholesterol and saturated fats, has long had low death rates from heart disease. More Cholesterol Current Events and Cholesterol News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||